Table of Contents
ISRN Hypertension
Volume 2013 (2013), Article ID 581651, 15 pages
http://dx.doi.org/10.5402/2013/581651
Review Article

Supplements and Foods with Potential Reduction of Blood Pressure in Prehypertensive and Hypertensive Subjects: A Systematic Review

1Department of Physical Education, Federal University of Paraíba, 58.051-900 João Pessoa, PB, Brazil
2Research Laboratory for Physical Training Applied to Performance and Health, Federal University of Paraíba, 58.051-900 João Pessoa, PB, Brazil
3Department of Nutrition, Federal University of Paraíba, 58.051-900 João Pessoa, PB, Brazil
4Instituição Federal University of Paraíba/Health Sciences Center Endereço: Campus I-Castelo Branco I, 58.051-900 João Pessoa, PB, Brazil

Received 25 January 2013; Accepted 18 February 2013

Academic Editors: Y. Iwashima, K. Karatzi, H. Komine, and A. A. Noorbala

Copyright © 2013 Aline de Freitas Brito et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. C. Lewicki, P. G. Kerr, and K. R. Polkinghorne, “Blood pressure and blood volume: acute and chronic considerations in hemodialysis,” Seminars in Dialysis, vol. 26, no. 1, pp. 62–72, 2013. View at Publisher · View at Google Scholar
  2. World Health Organization (WHO), “Obesity and overweight. Disponível,” Fact Sheet 311, 2012, http://www.who.int/mediacentre/factsheets/fs311/en/. View at Google Scholar
  3. American Diabetes Association, “Third-party reimbursement for diabetes care, self-management education, and supplies,” Diabetes Care, vol. 26, 1, pp. S143–S144, 2003. View at Google Scholar
  4. D. R. Velez, M. Guruju, G. Vinukonda, A. Prater, A. Kumar, and S. M. Williams, “Angiotensinogen promoter sequence variants in essential hypertension,” The American Journal of Hypertension, vol. 19, no. 12, pp. 1278–1285, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Yasunobu, K. Hayashi, T. Shingu, T. Yamagata, G. Kajiyama, and M. Kambe, “Coronary atherosclerosis and oxidative stress as reflected by autoantibodies against oxidized low-density lipoprotein and oxysterols,” Atherosclerosis, vol. 155, no. 2, pp. 445–453, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. M. T. Schram, N. Chaturvedi, C. Schalkwijk et al., “Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB prospective complications study,” Diabetes Care, vol. 26, no. 7, pp. 2165–2173, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. L. F. Masson, G. McNeill, and A. Avenell, “Genetic variation and the lipid response to dietary intervention: a systematic review,” The American Journal of Clinical Nutrition, vol. 77, no. 5, pp. 1098–1111, 2003. View at Google Scholar · View at Scopus
  8. L. P. Svetkey, T. J. Moore, D. G. Simons-Morton et al., “Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study,” Journal of Hypertension, vol. 19, no. 11, pp. 1949–1956, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. P. R. Conlin, D. Chow, E. R. Miller III et al., “The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial,” The American Journal of Hypertension, vol. 13, no. 9, pp. 949–955, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. Blumenthal, M. A. Babyak, A. Hinderliter et al., “Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study,” Archives of Internal Medicine, vol. 170, no. 2, pp. 126–135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. E. Berry, U. Z. Mulla, P. J. Chowienczyk, and T. A. B. Sanders, “Increased potassium intake from fruit and vegetables or supplements does not lower blood pressure or improve vascular function in UK men and women with early hypertension: a randomised controlled trial,” The British Journal of Nutrition, vol. 104, no. 12, pp. 1839–1847, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. J. A. Sugden, J. I. Davies, M. D. Witham, A. D. Morris, and A. D. Struthers, “Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels,” Diabetic Medicine, vol. 25, no. 3, pp. 320–325, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. G. C. Major, F. Alarie, J. Doré, S. Phouttama, and A. Tremblay, “Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations,” The American Journal of Clinical Nutrition, vol. 85, no. 1, pp. 54–59, 2007. View at Google Scholar · View at Scopus
  14. N. C. Ward, J. H. Wu, M. W. Clarke et al., “The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial,” Journal of Hypertension, vol. 25, no. 1, pp. 227–234, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Plantinga, L. Ghiadoni, A. Magagna et al., “Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients,” The American Journal of Hypertension, vol. 20, no. 4, pp. 392–397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. S. Farvid, M. Jalali, F. Siassi, N. Saadat, and M. Hosseini, “The impact of vitamins and/or mineral supplementation on blood pressure in type 2 diabetes,” Journal of the American College of Nutrition, vol. 23, no. 3, pp. 272–279, 2004. View at Google Scholar · View at Scopus
  17. N. C. Ward, J. M. Hodgson, K. D. Croft, V. Burke, L. J. Beilin, and I. B. Puddey, “Effects of vitamin C and grape-seed polyphenols on blood pressure in treated hypertensive individuals: results of a randomised double blind, placebo-controlled trial,” Asia Pacific Journal of Clinical Nutrition, vol. 12, supplement 18, 2003. View at Google Scholar
  18. M. Rodríguez-Morán and F. Guerrero-Romero, “Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial,” Diabetes Care, vol. 26, no. 4, pp. 1147–1152, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. O. M. Alarcón, Y. Guerrero, M. Ramírez de Fernández et al., “Efecto de la suplementación con cobre sobre los valores de presión arterial en pacientes con hipertensión moderada estable,” Archivos Latinoamericanos de Nutricion, vol. 53, no. 3, pp. 271–276, 2003. View at Google Scholar
  20. B. A. Mullan, I. S. Young, H. Fee, and D. R. McCance, “Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes,” Hypertension, vol. 40, no. 6, pp. 804–809, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Palumbo, F. Avanzini, C. Alli et al., “Effects of vitamin E on clinic and ambulatory blood pressure in treated hypertensive patients,” The American Journal of Hypertension, vol. 13, no. 5, pp. 564–567, 2000. View at Google Scholar · View at Scopus
  22. A. Gazis, D. J. White, S. R. Page, and J. R. Cockcroft, “Effect of oral vitamin E (α-tocopherol) supplementation on vascular endothelial function in type 2 diabetes mellitus,” Diabetic Medicine, vol. 16, no. 4, pp. 304–311, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Kawano, H. Yoshimi, H. Matsuoka, S. Takishita, and T. Omae, “Calcium supplementation in patients with essential hypertension: assessment by office, home and ambulatory blood pressure,” Journal of Hypertension, vol. 16, no. 11, pp. 1693–1699, 1998. View at Google Scholar · View at Scopus
  24. H. W. de Valk, R. Verkaaik, H. J. M. van Rijn, R. A. Geerdink, and A. Struyvenberg, “Oral magnesium supplementation in insulin-requiring Type 2 diabetic patients,” Diabetic Medicine, vol. 15, no. 6, pp. 503–507, 1998. View at Google Scholar
  25. A. Siani, P. Strazzullo, and L. Russo, “Controlled trial of long term oral potassium supplements in patients with mild hypertension,” The British Medical Journal, vol. 294, no. 6585, pp. 1453–1456, 1987. View at Google Scholar · View at Scopus
  26. S. Egert, A. Bosy-Westphal, J. Seiberl et al., “Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study,” British Journal of Nutrition, vol. 102, no. 7, pp. 1065–1074, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. N. C. Ward, J. M. Hodgson, K. D. Croft, V. Burke, L. J. Beilin, and I. B. Puddey, “The combination of vitamin C and grape-seed polyphenols increases blood pressure: a randomized, double-blind, placebo-controlled trial,” Journal of Hypertension, vol. 23, no. 2, pp. 427–434, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Aviram and B. Fuhrman, “Wine flavonoids protect against LDL oxidation and atherosclerosis,” Annals of the New York Academy of Sciences, vol. 957, pp. 146–161, 2002. View at Google Scholar · View at Scopus
  29. J. M. Hodgson, G. F. Watts, D. A. Playford, V. Burke, and K. D. Croft, “Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes,” European Journal of Clinical Nutrition, vol. 56, no. 11, pp. 1137–1142, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. B. E. Burke, R. Neuenschwander, and R. D. Olson, “Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension,” Southern Medical Journal, vol. 94, no. 11, pp. 1112–1117, 2001. View at Google Scholar · View at Scopus
  31. E. H. Lee, J. E. Park, Y. J. Choi, K. B. Huh, and W. Y. Kim, “A randomized study to establish the effects of spirulina in type 2 diabetes mellitus patients,” Nutrition Research and Practice, vol. 2, no. 4, pp. 295–300, 2008. View at Google Scholar
  32. P. V. Torres-Duran, A. Ferreira-Hermosillo, and M. A. Juarez-Oropeza, “Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of mexican population: a preliminary report,” Lipids in Health and Disease, vol. 6, article 33, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. S. G. West, A. Likos-Krick, P. Brown, and F. Mariotti, “Oral L-arginine improves hemodynamic response to stress and reduces plasma homocysteine in hypercholesterolemic men,” Journal of Nutrition, vol. 135, no. 2, pp. 212–217, 2005. View at Google Scholar · View at Scopus
  34. G. Duda, J. Suliburska, and D. Pupek-Musialik, “Effects of short-term garlic supplementation on lipid metabolism and antioxidant status in hypertensive adults,” Pharmacological Reports, vol. 60, no. 2, pp. 163–170, 2008. View at Google Scholar · View at Scopus
  35. S. Mizushima, K. Ohshige, J. Watanabe et al., “Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men,” The American Journal of Hypertension, vol. 17, no. 8, pp. 701–706, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. K. Park, J. S. Kim, and M. H. Kang, “Concord grape juice supplementation reduces blood pressure in Korean hypertensive men: double-blind, placebo controlled intervention trial,” BioFactors, vol. 22, no. 1–4, pp. 145–147, 2004. View at Google Scholar · View at Scopus
  37. V. Burke, J. M. Hodgson, L. J. Beilin, N. Giangiulioi, P. Rogers, and I. B. Puddey, “Dietary protein and soluble fiber reduce ambulatory blood pressure in treated hypertensives,” Hypertension, vol. 38, no. 4, pp. 821–826, 2001. View at Google Scholar · View at Scopus
  38. V. Vuksan, D. Whitham, J. L. Sievenpiper et al., “Supplementation of conventional therapy with the novel grain salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial,” Diabetes Care, vol. 30, no. 11, pp. 2804–2810, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. G. K. Paschos, F. Magkos, D. B. Panagiotakos, V. Votteas, and A. Zampelas, “Dietary supplementation with flaxseed oil lowers blood pressure in dyslipidaemic patients,” European Journal of Clinical Nutrition, vol. 61, no. 10, pp. 1201–1206, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Wang, A.-Q. Ma, S.-W. Song, Q.-H. Quan, X.-F. Zhao, and X.-H. Zheng, “Fish oil supplementation improves large arterial elasticity in overweight hypertensive patients,” European Journal of Clinical Nutrition, vol. 62, no. 12, pp. 1426–1431, 2008. View at Publisher · View at Google Scholar
  41. T. Iwata, T. Kamegai, Y. Yamauchi-Sato et al., “Safety of dietary conjugated linoleic acid (CLA) in a 12-weeks trial in healthy overweight Japanese male volunteers,” Journal of Oleo Science, vol. 56, no. 10, pp. 517–525, 2007. View at Google Scholar · View at Scopus
  42. M. Svensson, J. H. Christensen, J. Sølling, and E. B. Schmidt, “The effect of n-3 fatty acids on plasma lipids and lipoproteins and blood pressure in patients with CRF,” The American Journal of Kidney Diseases, vol. 44, no. 1, pp. 77–83, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. D. J. A. Jenkins, C. W. C. Kendall, A. Marchie et al., “Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial,” Circulation, vol. 106, no. 11, pp. 1327–1332, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Agerholm-Larsen, A. Raben, N. Haulrik, A. S. Hansen, M. Manders, and A. Astrup, “Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases,” European Journal of Clinical Nutrition, vol. 54, no. 4, pp. 288–297, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Shargorodsky, O. Debby, Z. Matas, and R. Zimlichman, “Effect of long-term treatment with antioxidants (vitamin C, vitamin E, coenzyme Q10 and selenium) on arterial compliance, humoral factors and inflammatory markers in patients with multiple cardiovascular risk factors,” Nutrition and Metabolism, vol. 7, article 55, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Minamiyama, S. Takemura, Y. Bito et al., “Supplementation of α-tocopherol improves cardiovascular risk factors via the insulin signalling pathway and reduction of mitochondrial reactive oxygen species in type II diabetic rats,” Free Radical Research, vol. 42, no. 3, pp. 261–271, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. K. K. Griendling and G. A. FitzGerald, “Oxidative Stress and Cardiovascular Injury. Part II: animal and Human Studies,” Circulation, vol. 108, no. 17, pp. 2034–2040, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Devaraj, A. Harris, and I. Jialal, “Modulation of monocyte-macrophage function with α-tocopherol: implications for atherosclerosis,” Nutrition Reviews, vol. 60, no. 1, pp. 8–14, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. M. G. Traber and J. F. Stevens, “Vitamins C and E: beneficial effects from a mechanistic perspective,” Free Radical Biology and Medicine, vol. 51, no. 5, pp. 1000–1013, 2011. View at Publisher · View at Google Scholar
  50. M. D. Fotherby, J. C. Williams, L. A. Forster, P. Craner, and G. A. Ferns, “Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons,” Journal of Hypertension, vol. 18, no. 4, pp. 411–415, 2000. View at Google Scholar · View at Scopus
  51. S. J. Duffy, N. Gokce, M. Holbrook et al., “Treatment of hypertension with ascorbic acid,” The Lancet, vol. 354, no. 9195, pp. 2048–2049, 1999. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Lykkesfeldt and H. E. Poulsen, “Is vitamin C supplementation beneficial? Lessons learned from randomised controlled trials,” The British Journal of Nutrition, vol. 103, no. 9, pp. 1251–1259, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. N. Gokce, J. F. Keaney Jr., B. Frei et al., “Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease,” Circulation, vol. 99, no. 25, pp. 3234–3240, 1999. View at Google Scholar · View at Scopus
  54. P. M. Kris-Etherton, A. H. Lichtenstein, B. V. Howard, D. Steinberg, and J. L. Witztum, “Antioxidant vitamin supplements and cardiovascular disease,” Circulation, vol. 110, no. 5, pp. 637–641, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. E. R. Miller, L. A. Lawrence, O. A. Levander, and D. M. Levine, “The effect of antioxidant vitamin supplementation on traditional cardiovascular risk factors,” Journal of Cardiovascular Risk, vol. 4, no. 1, pp. 19–24, 1997. View at Google Scholar · View at Scopus
  56. H. Han-Yao, “A factorial trial of vitamin C and vitamin E supplementation: no effect on blood pressure, but synergy in lowering total and LDL cholesterol,” in Proceedings of the 38th Annual Conference on Cardiovascular Disease Epidemiology and prevention, 1998.
  57. R. S. Gupta, E. S. Gupta, B. K. Dhakal, A. R. Thakur, and J. Ahnn, “Vitamin C and Vitamin E protect the rat testes from cadmium-induced reactive oxygen species,” Molecules and Cells, vol. 17, no. 1, pp. 132–139, 2004. View at Google Scholar
  58. H. Cai and D. G. Harrison, “Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress,” Circulation Research, vol. 87, no. 10, pp. 840–844, 2000. View at Google Scholar · View at Scopus
  59. G. Zalba, G. San José, M. U. Moreno et al., “Oxidative stress in arterial hypertension: role of NAD(P)H oxidase,” Hypertension, vol. 38, no. 6, pp. 1395–13959, 2001. View at Google Scholar
  60. M. F. Holick, “Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers,” Southern Medical Journal, vol. 98, no. 10, pp. 1024–1027, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Pfeifer, B. Begerow, H. W. Minne, D. Nachtigall, and C. Hansen, “Effects of a short-term vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 4, pp. 1633–1637, 2001. View at Publisher · View at Google Scholar · View at Scopus
  62. D. Zehnder, R. Bland, E. A. Walker et al., “Expression of 25-hydroxyvitamin D3-1α-hydroxylase in the human kidney,” Journal of the American Society of Nephrology, vol. 10, no. 12, pp. 2465–2473, 1999. View at Google Scholar · View at Scopus
  63. C. A. Papaharalambus and K. K. Griendling, “Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury,” Trends in Cardiovascular Medicine, vol. 17, no. 2, pp. 48–54, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. T. J. Kizhakekuttu and M. E. Widlansky, “Natural antioxidants and hypertension: promise and challenges,” Cardiovascular Therapeutics, vol. 28, no. 4, pp. e20–e32, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. I. C. W. Arts, D. R. Jacobs Jr., L. J. Harnack, M. Gross, and A. R. Folsom, “Dietary catechins in relation to coronary heart disease death among postmenopausal women,” Epidemiology, vol. 12, no. 6, pp. 668–675, 2001. View at Publisher · View at Google Scholar · View at Scopus
  66. I. C. Arts and P. C. Hollman, “Polyphenols and disease risk in epidemiologic studies,” The American Journal of Clinical Nutrition, vol. 81, no. 1, pp. 317S–325S, 2005. View at Google Scholar · View at Scopus
  67. U. Peters, C. Poole, and L. Arab, “Does tea affect cardiovascular disease? A meta-analysis,” The American Journal of Epidemiology, vol. 154, no. 6, pp. 495–503, 2001. View at Publisher · View at Google Scholar · View at Scopus
  68. L. A. Bazzano, J. He, L. G. Ogden et al., “Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study,” The American Journal of Clinical Nutrition, vol. 76, no. 1, pp. 93–99, 2002. View at Google Scholar · View at Scopus
  69. S. B. Lotito and B. Frei, “Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon?” Free Radical Biology and Medicine, vol. 41, no. 12, pp. 1727–1746, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. P. J. Mink, C. G. Scrafford, L. M. Barraj et al., “Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women,” The American Journal of Clinical Nutrition, vol. 85, no. 3, pp. 895–909, 2007. View at Google Scholar · View at Scopus
  71. A. Cherubini, C. Ruggiero, C. Morand et al., “Dietary antioxidants as potential pharmacological agents for ischemic stroke,” Current Medicinal Chemistry, vol. 15, no. 12, pp. 1236–1248, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. K. B. Pandey and S. I. Rizvi, “Plant polyphenols as dietary antioxidants in human health and disease,” Oxidative Medicine and Cellular Longevity, vol. 2, no. 5, pp. 270–278, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. T. Baster and C. Baster-Brooks, “Exercise and hypertension,” Australian Family Physician, vol. 34, no. 6, pp. 419–424, 2005. View at Google Scholar · View at Scopus
  74. K. Overvad, B. Diamant, L. Holm, G. Hølmer, S. A. Mortensen, and S. Stender, “Coenzyme Q10 in health and disease,” European Journal of Clinical Nutrition, vol. 53, no. 10, pp. 764–770, 1999. View at Google Scholar · View at Scopus
  75. T. Wallerath, G. Deckert, T. Ternes et al., “Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase,” Circulation, vol. 106, no. 13, pp. 1652–1658, 2002. View at Publisher · View at Google Scholar · View at Scopus
  76. C. Heiss, A. Dejam, P. Kleinbongard, T. Schewe, H. Sies, and M. Kelm, “Vascular effects of cocoa rich in Flavan-3-ols,” Journal of the American Medical Association, vol. 290, no. 8, pp. 1030–1031, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. E. Anter, S. R. Thomas, E. Schulz, O. M. Shapira, J. A. Vita, and J. F. Keaney Jr., “Activation of endothelial nitric-oxide synthase by the p38 MAPK in response to black tea polyphenols,” Journal of Biological Chemistry, vol. 279, no. 45, pp. 46637–46643, 2004. View at Publisher · View at Google Scholar · View at Scopus
  78. J. F. Leikert, T. R. Räthel, P. Wohlfart, V. Cheynier, A. M. Vollmar, and V. M. Dirsch, “Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells,” Circulation, vol. 106, no. 13, pp. 1614–1617, 2002. View at Publisher · View at Google Scholar · View at Scopus
  79. C. A. Schmitt and V. M. Dirsch, “Modulation of endothelial nitric oxide by plant-derived products,” Nitric Oxide, vol. 21, no. 2, pp. 77–91, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. J. C. Stoclet, T. Chataigneau, M. Ndiaye et al., “Vascular protection by dietary polyphenols,” European Journal of Pharmacology, vol. 500, no. 1–3, pp. 299–313, 2004. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Aviram and L. Dornfeld, “Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure,” Atherosclerosis, vol. 158, no. 1, pp. 195–198, 2001. View at Publisher · View at Google Scholar · View at Scopus
  82. Y. J. Jeong, Y. J. Choi, H. M. Kwon et al., “Differential inhibition of oxidized LDL-induced apoptosis in human endothelial cells treated with different flavonoids,” The British Journal of Nutrition, vol. 93, no. 5, pp. 581–591, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. B. Fuhrman, N. Volkova, R. Coleman, and M. Aviram, “Grape powder polyphenols attenuate atherosclerosis development in apolipoprotein E deficient (E0) mice and reduce macrophage atherogenicity,” Journal of Nutrition, vol. 135, no. 4, pp. 722–728, 2005. View at Google Scholar · View at Scopus
  84. A. Ludwig, M. Lorenz, N. Grimbo et al., “The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells,” Biochemical and Biophysical Research Communications, vol. 316, no. 3, pp. 659–665, 2004. View at Publisher · View at Google Scholar · View at Scopus
  85. J. M. Hodgson and K. D. Croft, “Dietary flavonoids: effects on endothelial function and blood pressure,” Journal of the Science of Food and Agriculture, vol. 86, no. 15, pp. 2492–2498, 2006. View at Publisher · View at Google Scholar · View at Scopus
  86. Y. Guan, H. Y. Zhao, X. F. Ding, and Y. Y. Zhu, “Analysis of the contents of elements in spinrulina from different producing areas,” Guang Pu Xue Yu Guang Pu Fen Xi, vol. 27, no. 5, pp. 1029–1031, 2007. View at Google Scholar · View at Scopus
  87. J. P. Lekakis, S. Papathanassiou, T. G. Papaioannou et al., “Oral L-arginine improves endothelial dysfunction in patients with essential hypertension,” International Journal of Cardiology, vol. 86, no. 2-3, pp. 317–323, 2002. View at Publisher · View at Google Scholar · View at Scopus
  88. Z. Khan, P. Bhadouria, and P. S. Bisen, “Nutritional and therapeutic potential of Spirulina,” Current Pharmaceutical Biotechnology, vol. 6, no. 5, pp. 373–379, 2005. View at Publisher · View at Google Scholar · View at Scopus
  89. D. Mascher, M. C. Paredes-Carbajal, P. V. Torres-Durán, J. Zamora-González, J. C. Díaz-Zagoya, and M. A. Juárez-Oropeza, “Ethanolic extract of Spirulina maxima alters the vasomotor reactivity of aortic rings from obese rats,” Archives of Medical Research, vol. 37, no. 1, pp. 50–57, 2006. View at Publisher · View at Google Scholar · View at Scopus
  90. P. Parikh, U. Mani, and U. Iyer, “Role of Spirulina in the control of glycemia and lipidemia in type 2 diabetes mellitus,” Journal of Medicinal Food, vol. 4, no. 4, pp. 193–199, 2001. View at Google Scholar · View at Scopus
  91. G. Hsiao, P. O. H. Chou, M. Y. Shen, D. S. Chou, C. H. Lin, and J. R. Sheu, “C-phycocyanin, a very potent and novel platelet aggregation inhibitor from Spirulina platensis,” Journal of Agricultural and Food Chemistry, vol. 53, no. 20, pp. 7734–7740, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. V. Martina, A. Masha, V. R. Gigliardi et al., “Long-term n-acetylcysteine and l-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes,” Diabetes Care, vol. 31, no. 5, pp. 940–944, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. K. Rytlewski, R. Olszanecki, R. Korbut, and Z. Zdebski, “Effects of prolonged oral supplementation with L-arginine on blood pressure and nitric oxide synthesis in preeclampsia,” European Journal of Clinical Investigation, vol. 35, no. 1, pp. 32–37, 2005. View at Publisher · View at Google Scholar · View at Scopus
  94. Y. Higashi and M. Yoshizumi, “Exercise and endothelial function: role of endothelium-derived nitric oxide and oxidative stress in healthy subjects and hypertensive patients,” Pharmacology and Therapeutics, vol. 102, no. 1, pp. 87–96, 2004. View at Publisher · View at Google Scholar · View at Scopus
  95. V. Dhawan and S. Jain, “Effect of garlic supplementation on oxidized low density lipoproteins and lipid peroxidation in patients of essential hypertension,” Molecular and Cellular Biochemistry, vol. 266, no. 1-2, pp. 109–115, 2004. View at Publisher · View at Google Scholar · View at Scopus
  96. I. Durak, M. Kavutcu, B. Aytaç et al., “Effects of garlic extract consumption on blood lipid and oxidant/antioxidant parameters in humans with high blood cholesterol,” Journal of Nutritional Biochemistry, vol. 15, no. 6, pp. 373–377, 2004. View at Publisher · View at Google Scholar · View at Scopus
  97. L. D. Brace, “Cardiovascular benefits of garlic (Allium sativum L),” The Journal of Cardiovascular Nursing, vol. 16, no. 4, pp. 33–49, 2002. View at Google Scholar · View at Scopus
  98. R. Gebhardt and H. Beck, “Differential inhibitory effects of garlic-derived organosulfur compounds on cholesterol biosynthesis in primary rat hepatocyte cultures,” Lipids, vol. 31, no. 12, pp. 1269–1276, 1996. View at Publisher · View at Google Scholar · View at Scopus
  99. S. Warshafsky, R. S. Kamer, and S. L. Sivak, “Effect of garlic on total serum cholesterol: a meta-analysis,” Annals of Internal Medicine, vol. 119, no. 7 I, pp. 599–605, 1993. View at Google Scholar · View at Scopus
  100. L. H. Opie and S. Lecour, “The red wine hypothesis: from concepts to protective signalling molecules,” European Heart Journal, vol. 28, no. 14, pp. 1683–1693, 2007. View at Publisher · View at Google Scholar · View at Scopus
  101. M. Diebolt, B. Bucher, and R. Andriantsitohaina, “Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression,” Hypertension, vol. 38, no. 2, pp. 159–165, 2001. View at Google Scholar · View at Scopus
  102. Y. Nakamura, N. Yamamoto, K. Sakai, and T. Takano, “Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme,” Journal of Dairy Science, vol. 78, no. 6, pp. 1253–1257, 1995. View at Google Scholar · View at Scopus
  103. M. Feinleib, C. Lenfant, and S. A. Miller, “Hypertension and calcium,” Science, vol. 226, no. 4673, pp. 384–389, 1984. View at Google Scholar · View at Scopus
  104. D. Grassi, S. Necozione, C. Lippi et al., “Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives,” Hypertension, vol. 46, no. 2, pp. 398–405, 2005. View at Publisher · View at Google Scholar · View at Scopus
  105. A. Figueroa, M. A. Sanchez-Gonzalez, A. Wong, and B. H. Arjmandi, “Effects of dark chocolate on blood pressure in patients with hypertension,” The American Journl of Hypertension, vol. 25, no. 6, pp. 649–643, 2012. View at Google Scholar
  106. M. H. Williams, “Dietary supplements and sports performance: introduction and vitamins,” Journal of the International Society of Sports Nutrition, vol. 1, no. 2, pp. 1–6, 2004. View at Google Scholar
  107. J. Sundgot-Borgen, B. Berglund, and M. K. Torstveit, “Nutritional supplements in Norwegian elite athletes: impact of international ranking and advisors,” Scandinavian Journal of Medicine and Science in Sports, vol. 13, no. 2, pp. 138–144, 2003. View at Publisher · View at Google Scholar · View at Scopus